Clinical trial
Radiation Therapy in Treating Patients With Brain Cancer
NCT00002620 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00002620 |
|---|---|
| Title | Radiation Therapy in Treating Patients With Brain Cancer |
| Official title | EFFECT OF DIBROMODULCITOL PLUS BCNU ON FREE INTERVAL AND SURVIVAL OF PATIENTS WITH SUPRATENTORIAL MALIGNANT BRAIN GLIOMAS, A PHASE III TYPE STUDY |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Radiation |
| Interventions | carmustine, chemotherapy, mitolactol, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy |
| Enrollment | 212 |
| Start date | Nov 1, 1994 |
| Primary completion | Jun 1, 2000 |
| First posted | Jul 19, 2004 |
| Last update posted | Jul 2, 2012 |
| Countries | Austria, Belgium, Germany, Italy, Netherlands, Portugal, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: